$FLGT
Fulgent Genetics, Inc.

2018 Q4 Form 10-K Financial Statement

#000156459020010617 Filed on March 13, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $5.673M $5.625M $5.400M
YoY Change 32.52% 24.92% 16.38%
Cost Of Revenue $2.769M $2.612M $2.544M
YoY Change 8.8% 15.17% 35.39%
Gross Profit $2.904M $3.013M $2.856M
YoY Change 67.28% 34.81% 3.44%
Gross Profit Margin 51.19% 53.56% 52.89%
Selling, General & Admin $2.507M $2.421M $2.645M
YoY Change 1.01% -6.45% 32.85%
% of Gross Profit 86.33% 80.35% 92.61%
Research & Development $1.426M $1.438M $1.212M
YoY Change 7.7% 27.48% 31.74%
% of Gross Profit 49.1% 47.73% 42.44%
Depreciation & Amortization $600.0K $547.0K $562.0K
YoY Change 50.0% 24.89% 38.77%
% of Gross Profit 20.66% 18.15% 19.68%
Operating Expenses $3.933M $3.859M $3.857M
YoY Change 3.34% 3.85% 32.5%
Operating Profit -$1.029M -$846.0K -$1.001M
YoY Change -50.29% -42.88% 567.33%
Interest Expense $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$931.0K -$703.0K -$903.0K
YoY Change -52.81% -47.38% 2910.0%
Income Tax $888.0K -$318.0K -$100.0K
% Of Pretax Income
Net Earnings -$2.053M -$595.0K -$1.049M
YoY Change 26.42% -45.56% 4096.0%
Net Earnings / Revenue -36.19% -10.58% -19.43%
Basic Earnings Per Share -$0.11 -$0.03 -$0.06
Diluted Earnings Per Share -$0.11 -$0.03 -$0.06
COMMON SHARES
Basic Shares Outstanding 18.07M 18.01M 17.92M
Diluted Shares Outstanding 18.01M 17.92M

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.03M $32.60M $30.60M
YoY Change 17.18% 25.4% 5.88%
Cash & Equivalents $6.736M $8.489M $3.654M
Short-Term Investments $24.30M $24.11M $26.90M
Other Short-Term Assets $2.561M $2.370M $1.000M
YoY Change 5.05% 115.45% 11.11%
Inventory
Prepaid Expenses $556.0K $568.0K
Receivables $5.948M $6.077M $5.100M
Other Receivables $70.00K $1.600M $42.00K
Total Short-Term Assets $39.54M $41.05M $38.20M
YoY Change 20.09% 28.28% 10.09%
LONG-TERM ASSETS
Property, Plant & Equipment $6.446M $6.900M $7.300M
YoY Change -11.36% 6.15% 8.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.512M $1.746M $9.400M
YoY Change -21.94% -20.05% -9052.38%
Other Assets $17.00K $18.00K $600.0K
YoY Change -56.41% -82.0% 500.0%
Total Long-Term Assets $14.36M $13.75M $17.30M
YoY Change -40.8% -48.44% -28.23%
TOTAL ASSETS
Total Short-Term Assets $39.54M $41.05M $38.20M
Total Long-Term Assets $14.36M $13.75M $17.30M
Total Assets $53.90M $54.80M $55.50M
YoY Change -5.74% -6.6% -5.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.313M $1.000M $1.800M
YoY Change -37.15% -57.81% -1.1%
Accrued Expenses $1.259M $1.200M $1.200M
YoY Change 38.2% 53.65% 33.04%
Deferred Revenue $166.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.738M $2.300M $3.000M
YoY Change -8.73% -27.01% 7.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $14.00K $11.00K $0.00
YoY Change 133.33% 120.0%
Total Long-Term Liabilities $14.00K $11.00K $0.00
YoY Change 133.33% 120.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.738M $2.300M $3.000M
Total Long-Term Liabilities $14.00K $11.00K $0.00
Total Liabilities $2.752M $2.300M $3.000M
YoY Change -8.45% -32.33% -3.23%
SHAREHOLDERS EQUITY
Retained Earnings -$63.02M
YoY Change 9.28%
Common Stock $114.2M
YoY Change 2.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $51.15M $52.58M $52.56M
YoY Change
Total Liabilities & Shareholders Equity $53.90M $54.80M $55.50M
YoY Change -5.74% -6.6% -5.61%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$2.053M -$595.0K -$1.049M
YoY Change 26.42% -45.56% 4096.0%
Depreciation, Depletion And Amortization $600.0K $547.0K $562.0K
YoY Change 50.0% 24.89% 38.77%
Cash From Operating Activities $800.0K -$200.0K $0.00
YoY Change -161.54% -140.0% -100.0%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$1.000M -$100.0K
YoY Change -90.91% 233.33% -92.86%
Acquisitions
YoY Change
Other Investing Activities -$2.400M $6.000M -$1.500M
YoY Change 242.86% -360.87% -126.79%
Cash From Investing Activities -$2.500M $5.000M -$1.600M
YoY Change 47.06% -292.31% -138.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 800.0K -200.0K 0.000
Cash From Investing Activities -2.500M 5.000M -1.600M
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -1.700M 4.800M -1.600M
YoY Change -43.33% -328.57% -133.33%
FREE CASH FLOW
Cash From Operating Activities $800.0K -$200.0K $0.00
Capital Expenditures -$100.0K -$1.000M -$100.0K
Free Cash Flow $900.0K $800.0K $100.0K
YoY Change -550.0% 0.0% -95.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 dei Entity Public Float
EntityPublicFloat
38800000
CY2019 dei Entity File Number
EntityFileNumber
001-37894
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2621304
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
4978 Santa Anita Avenue
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11965000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6736000
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
16304000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
24298000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2561000
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 205
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Temple City
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91780
CY2019 dei City Area Code
CityAreaCode
626
CY2019 dei Local Phone Number
LocalPhoneNumber
350-0537
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21564971
CY2019Q4 us-gaap Liabilities
Liabilities
5979000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6555000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5948000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2255000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
37079000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
872000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5974000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
146000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63429000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-428000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21483000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21483000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
146058000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
82777000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6537000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5898000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6414000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88756000
CY2019 us-gaap Operating Expenses
OperatingExpenses
18849000
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
837000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
409000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2738000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
751000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4652000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
365000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
420000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018 us-gaap Interest And Other Income
InterestAndOtherIncome
434000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5538000
CY2018 us-gaap Operating Expenses
OperatingExpenses
15724000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4636000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2018 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.31
CY2019 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2018 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.31
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18709000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17978000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18709000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17978000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-17000
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-44000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
198000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
53000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-230000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5598000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
251000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17000
CY2019Q4 us-gaap Assets
Assets
88756000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1581000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1313000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1333000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
24000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
166000
CY2018Q4 us-gaap Liabilities
Liabilities
2752000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114203000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63018000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
51152000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53904000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
590000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18172000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18172000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2256000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
39543000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
41947000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
6386000
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1512000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6446000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2633000
CY2018Q4 us-gaap Assets
Assets
53904000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1259000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-5070000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
54178000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2304000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000
CY2018 us-gaap Cumulative Effect On Retained Earnings Before Tax1
CumulativeEffectOnRetainedEarningsBeforeTax1
327000
CY2018 us-gaap Cumulative Effect On Retained Earnings Tax1
CumulativeEffectOnRetainedEarningsTax1
74000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3209000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
38000
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
181000
CY2019 us-gaap Profit Loss
ProfitLoss
-411000
CY2018 us-gaap Profit Loss
ProfitLoss
-5607000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3209000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2304000
CY2019 us-gaap Depreciation
Depreciation
2107000
CY2018 us-gaap Depreciation
Depreciation
2163000
CY2019 flgt Noncash Lease Expense
NoncashLeaseExpense
413000
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-11000
CY2018 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-88000
CY2019 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
106000
CY2018 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
297000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
189000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
309000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-21000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-52000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-374000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-91000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
264000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
533000
CY2019 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
24000
CY2019 flgt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-409000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-675000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2322000
CY2018 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
510000
CY2019 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
557000
CY2018 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
85000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
110000
CY2019 flgt Noncash Or Part Noncash Public Offering Costs Included In Accounts Payable
NoncashOrPartNoncashPublicOfferingCostsIncludedInAccountsPayable
129000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11965000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
20000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
950000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28758000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28775000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17000
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-44000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5229000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
246000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6736000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6490000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments, assumptions and decisions that affect the reported amounts and related disclosures, including the selection of appropriate accounting policies and the assumptions on which to base accounting estimates. In making these estimates and assumptions and reaching these decisions, the Company applies judgment based on its understanding and analysis of the relevant circumstances, including historical data and experience available at the date of the accompanying consolidated financial statements, as well as various other factors management believes to be reasonable under the circumstances. Actual results could differ from these estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an on-going basis, management evaluates its estimates, primarily those related to: (i) revenue recognition criteria, (ii) accounts receivable and allowances for doubtful accounts, (iii) the useful lives of fixed assets, (iv) estimates of tax liabilities and (v) the valuation of equity-based awards.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-249000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-280000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk, Customers and Suppliers</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, accounts receivable and marketable securities, which consist of debt securities, and cash equivalents. As of December&#160;31, 2019, substantially all of the Company&#8217;s cash and cash equivalents were deposited in accounts at financial institutions, and amounts may exceed federally insured limits. Management believes that the Company is not exposed to significant credit risk due to the financial strength of the depository institutions in which its cash and cash equivalents are held.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain periods, a small number of customers has accounted for a significant portion of the Company&#8217;s revenue. Aggregating customers that are under common control or are affiliates, one customer comprised 28% of total revenue in the year ended December 31, 2019, and one customer comprised 13% of total revenue in the year ended December 31, 2018. No customer comprised at least 10% of total accounts receivable as of December 31, 2019. One customer comprised 18% of total accounts receivable as of December 31, 2018.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from the U.S. government was less than 10% of total revenue in each of the years ended December 31, 2019 and 2018.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company relies on a limited number of suppliers for certain laboratory substances used in the chemical reactions incorporated into its processes, referred to as reagents, as well as for the sequencers and various other equipment and materials it uses in its laboratory operations. In particular, the Company relies on a sole supplier for the next generation sequencers and associated reagents it uses to perform its genetic tests and as the sole provider of maintenance and repair services for these sequencers. The Company&#8217;s laboratory operations would be interrupted if it encounters delays or difficulties securing these reagents, sequencers, other equipment or materials or maintenance and repair services, which could occur for a variety of reasons, including if the Company needs a replacement or temporary substitute for any of its limited or sole suppliers and is not able to locate and make arrangements with an acceptable replacement or temporary substitute. The Company believes there are currently only a few other manufacturers that are capable of supplying and servicing some of the equipment and other materials necessary for its laboratory operations, including sequencers and various associated reagents.&nbsp;&nbsp;</p>
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
532000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3192000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
516000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2676000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
560000
CY2018Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
21000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
287000
CY2019 flgt Bad Debt Expense
BadDebtExpense
189000
CY2018 flgt Bad Debt Expense
BadDebtExpense
309000
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
28000
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6000
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2019 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ShippingAndHandlingMember
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
59000
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16000
CY2019 us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3000000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3000000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
58124000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
159000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
32000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
58251000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
6399000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
30776000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
104000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
30684000
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2692000
CY2019 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
32000
CY2018 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
104000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2019Q4 flgt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2018Q4 flgt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2019 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2018 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13964000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12332000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7990000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5886000
CY2019Q4 flgt Reagents Current
ReagentsCurrent
277000
CY2018Q4 flgt Reagents Current
ReagentsCurrent
314000
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
150000
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
150000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1288000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
556000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
46000
CY2018Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1251000
CY2019Q4 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
478000
CY2018Q4 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
220000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16000
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
70000
CY2019 flgt Operating Leases Term Of Expiration
OperatingLeasesTermOfExpiration
2023-08
CY2019Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2019 flgt Operating Lease Expense Including Sublease Consideration
OperatingLeaseExpenseIncludingSubleaseConsideration
548000
CY2018 flgt Operating Lease Expense Including Sublease Consideration
OperatingLeaseExpenseIncludingSubleaseConsideration
418000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
384000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2600000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
587000
CY2019 flgt Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
535000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0625
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
575000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
591000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
597000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
567000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
330000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-529000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1331000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
559000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
550000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
558000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
567000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
862000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3656000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3209000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2304000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
679000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4602000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-270000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-34000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
38000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
43000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-987000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-308000
CY2018 flgt Deferred Income Tax Expense Benefit Including Of Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitIncludingOfChangeInValuationAllowance
36000
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.4676
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0437
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.1383
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.5353
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0408
CY2019 flgt Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.5711
CY2018 flgt Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.0231
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
0.0387
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
-0.0013
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0022
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1.2922
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2390
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1053
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0065
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
97000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
118000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
180000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
136000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
445000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
699000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
609000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
579000
CY2019Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
8000
CY2018Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
9000
CY2019Q4 flgt Deferred Tax Assets Foreign Taxes
DeferredTaxAssetsForeignTaxes
545000
CY2018Q4 flgt Deferred Tax Assets Foreign Taxes
DeferredTaxAssetsForeignTaxes
343000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
680000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
261000
CY2019Q4 flgt Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
643000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3207000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2166000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2125000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1448000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1082000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
718000
CY2019Q4 flgt Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
419000
CY2018Q4 flgt Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
644000
CY2019Q4 flgt Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
633000
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
30000
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
74000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1082000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
718000
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
237000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
176000
CY2019Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2018Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8387000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10347000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8424000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5370000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5673000
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
3634000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
3885000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
3620000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
2968000
CY2018Q4 us-gaap Cost Of Revenue
CostOfRevenue
2769000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
2612000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
2544000
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
2772000
CY2019Q4 us-gaap Gross Profit
GrossProfit
4753000
CY2019Q3 us-gaap Gross Profit
GrossProfit
6462000
CY2019Q2 us-gaap Gross Profit
GrossProfit
4804000
CY2019Q1 us-gaap Gross Profit
GrossProfit
2402000
CY2018Q4 us-gaap Gross Profit
GrossProfit
2904000
CY2018Q3 us-gaap Gross Profit
GrossProfit
3013000
CY2018Q2 us-gaap Gross Profit
GrossProfit
2856000
CY2018Q1 us-gaap Gross Profit
GrossProfit
1881000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1795000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1744000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1574000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1424000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1426000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1438000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1212000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1458000
CY2019Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1635000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1687000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1304000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1272000
CY2018Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1128000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1115000
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1279000
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1130000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1732000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1522000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1631000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1529000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1379000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1306000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1366000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1487000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
5162000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
4953000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4509000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
4225000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
3933000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3859000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
3857000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
4075000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-409000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1509000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
295000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1823000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1029000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-846000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1001000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2194000
CY2019Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
249000
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
189000
CY2019Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
192000
CY2019Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
207000
CY2018Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
98000
CY2018Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
143000
CY2018Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
98000
CY2018Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
95000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-160000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1698000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
487000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1616000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-931000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-703000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-903000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2099000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
888000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-318000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-434000
CY2019Q4 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-122000
CY2019Q3 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
1637000
CY2019Q2 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
480000
CY2019Q1 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1629000
CY2018Q4 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1819000
CY2018Q3 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-385000
CY2018Q2 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-803000
CY2018Q1 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1665000
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-174000
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-175000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-149000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-279000
CY2018Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-234000
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-210000
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-246000
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-245000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-296000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1462000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
331000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1908000
CY2019Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.08
CY2019Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.10
CY2018Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2019Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.08
CY2019Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.10

Files In Submission

Name View Source Status
0001564590-20-010617-index-headers.html Edgar Link pending
0001564590-20-010617-index.html Edgar Link pending
0001564590-20-010617.txt Edgar Link pending
0001564590-20-010617-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
flgt-10k_20191231.htm Edgar Link pending
flgt-20191231.xml Edgar Link completed
flgt-20191231.xsd Edgar Link pending
flgt-20191231_cal.xml Edgar Link unprocessable
flgt-20191231_def.xml Edgar Link unprocessable
flgt-20191231_lab.xml Edgar Link unprocessable
flgt-20191231_pre.xml Edgar Link unprocessable
flgt-ex231_58.htm Edgar Link pending
flgt-ex311_59.htm Edgar Link pending
flgt-ex312_57.htm Edgar Link pending
flgt-ex321_56.htm Edgar Link pending
flgt-ex43_60.htm Edgar Link pending
gd5mgffqbzg1000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending